Quercis Pharma Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$150M
- Investors
-
2
Quercis Pharma General Information
Description
Operator of an antithrombotic platform intended to deliver safe and accessible treatments to patients with potentially life-threatening conditions. The company's platform focuses on the prevention of venous thrombosis and pulmonary embolism in high-risk cancer patients that arrest and reverse platelet aggregation with a profile that conveys lowered bleeding risk compared to the current standard of care, enabling healthcare sectors to offer access to potentially life-saving therapies at an affordable cost.
Contact Information
Website
www.quercis.comCorporate Office
- Nordstrass 5
- 6300 Zug
- Switzerland
Corporate Office
- Nordstrass 5
- 6300 Zug
- Switzerland
Quercis Pharma Timeline
Quercis Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 09-Dec-2021 | $150M | Completed | Clinical Trials - Phase 2 | ||
| 1. Early Stage VC | 01-Dec-2020 | Completed | Startup |
Quercis Pharma Comparisons
Industry
Financing
Details
Quercis Pharma Competitors (4)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| T3 Pharmaceuticals | Formerly VC-backed | Allschwil, Switzerland | ||||
| Anaveon | Venture Capital-Backed | Basel, Switzerland | ||||
| iOnctura | Venture Capital-Backed | Genève, Switzerland | ||||
| Araris | Venture Capital-Backed | Zurich, Switzerland |
Quercis Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Quercis Pharma Patents
Quercis Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220370401-A1 | Method for treating amyotrophic lateral sclerosis using quercetin-containing compositions | Pending | 19-May-2021 | ||
| AU-2022276190-A1 | Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis | Pending | 19-May-2021 | ||
| CA-3219671-A1 | Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis | Pending | 19-May-2021 | ||
| EP-4340828-A1 | Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis | Pending | 19-May-2021 | ||
| US-20220096432-A1 | Method for treating zika virus infection with quercetin-containing compositions | Inactive | 03-Feb-2016 | A61K31/352 |
Quercis Pharma Executive Team (9)
| Name | Title | Board Seat |
|---|---|---|
| Thomas Lines | Founder, Chief Executive Officer & Board Member | |
| Stefan Wohlfeil MD | Senior Advisor to the CEO | |
| Simone Schurle-Finke Ph.D | Member of Scientific Advisory Board | |
| Fabio Dorigotti | Chief Medical Officer | |
| Richard O'Neil JD | Chief Legal Officer |
Quercis Pharma Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Beat Kraehenmann | Self | Board Member | |
| Chris Springer | Self | Board Member | |
| Ilias Läber Ph.D | Self | Chairman | |
| Ilona Leitendorfa | Self | Board Member | |
| Jean-Pierre Bizzari MD | Self | Chairman of Scientific Advisory Board |
Quercis Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Quercis Pharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Global Emerging Markets | PE/Buyout | Minority | ||
| Oak Investment Partners | Venture Capital | Minority |
Quercis Pharma FAQs
-
When was Quercis Pharma founded?
Quercis Pharma was founded in 2018.
-
Who is the founder of Quercis Pharma?
Thomas Lines is the founder of Quercis Pharma.
-
Who is the CEO of Quercis Pharma?
Thomas Lines is the CEO of Quercis Pharma.
-
Where is Quercis Pharma headquartered?
Quercis Pharma is headquartered in Zug, Switzerland.
-
What is the size of Quercis Pharma?
Quercis Pharma has 3 total employees.
-
What industry is Quercis Pharma in?
Quercis Pharma’s primary industry is Drug Discovery.
-
Is Quercis Pharma a private or public company?
Quercis Pharma is a Private company.
-
What is Quercis Pharma’s current revenue?
The current revenue for Quercis Pharma is .
-
How much funding has Quercis Pharma raised over time?
Quercis Pharma has raised $150M.
-
Who are Quercis Pharma’s investors?
Global Emerging Markets and Oak Investment Partners have invested in Quercis Pharma.
-
Who are Quercis Pharma’s competitors?
T3 Pharmaceuticals, Anaveon, iOnctura, and Araris are competitors of Quercis Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
